ProKidney Corp.
PROK
$1.67
-$0.04-2.34%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -1.74% | 196.05% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.74% | 196.05% | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -1.74% | 196.05% | -- | -- | -- |
| SG&A Expenses | -21.16% | -0.92% | -6.31% | 2.90% | 11.77% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.51% | -11.10% | -11.94% | -7.26% | 3.85% |
| Operating Income | -8.57% | 11.41% | 12.44% | 7.77% | -3.27% |
| Income Before Tax | -14.08% | 9.29% | 18.69% | 6.24% | -6.03% |
| Income Tax Expenses | -- | -193.13% | 123.91% | 1,614.29% | 503.06% |
| Earnings from Continuing Operations | -12.30% | 15.74% | 12.69% | 3.90% | -7.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 6.44% | -20.53% | -16.29% | -21.37% | -17.89% |
| Net Income | -19.74% | 9.62% | 8.05% | -32.35% | -76.30% |
| EBIT | -8.57% | 11.41% | 12.44% | 7.77% | -3.27% |
| EBITDA | -8.76% | 12.29% | 13.32% | 8.48% | -2.09% |
| EPS Basic | -7.13% | 17.83% | 14.02% | 23.18% | 15.35% |
| Normalized Basic EPS | -70.24% | -127.67% | -253.85% | -166.53% | -126.79% |
| EPS Diluted | -7.13% | 17.83% | 14.02% | 23.18% | 15.35% |
| Normalized Diluted EPS | -70.24% | -127.67% | -253.85% | -166.53% | -126.79% |
| Average Basic Shares Outstanding | 11.77% | 9.98% | 6.99% | 72.22% | 108.32% |
| Average Diluted Shares Outstanding | 11.77% | 9.98% | 6.99% | 72.22% | 108.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |